PALO ALTO, CA, Aug 14, 2025 – Diagnosing brain disorders often comes down to sifting through mountains of EEG data. LVIS Corporation has expanded its NeuroMatch platform with ambulatory EEG capabilities, aiming to address one of neurology’s most labor-intensive tasks. Ambulatory EEG records continuous brain activity over several days while patients follow their normal routines, making it useful for diagnosing conditions such as epilepsy. Traditionally, these studies generate tens of thousands of EEG segments, each requiring manual review by specialists – a process that is time-consuming. The new capability is designed to streamline this workflow, reducing the manual burden while preserving diagnostic accuracy.
With NeuroMatch’s ambulatory EEG functionality, LVIS addresses several of the challenges that have made ambulatory EEG review inefficient for clinicians.
The platform uses AI to process large EEG data sets. It detects neurological events and marks them for review. It also filters out common artifacts, such as muscle and eye movements. The system runs in a web browser and does not require installation of any specific hardware.
“Ambulatory EEG is essential, but it’s been incredibly resource-intensive for both physicians and technicians,” said Jin Hyung Lee, founder of LVIS Corporation. “With this NeuroMatch update, we’ve built an intelligent, streamlined experience that lets clinicians focus only on what matters most – making faster, more confident diagnoses.”
These features allow healthcare providers to launch, monitor, and interpret ambulatory EEG studies from any internet-connected device. Physicians can move between locations – such as the hospital, home, or office – while continuing their review and reporting without switching between different systems. Reports can be completed, signed, and delivered within the same platform. The cloud-based system supports collaboration across multiple sites and maintains data quality.
NeuroMatch features seizure and spike trend visualizations, customizable report templates, daily summaries, integrated annotations, and secure digital signatures. These features align with existing clinical workflows, supporting neurologists in diagnosis without adding further complexities.
As healthcare expands outside hospital settings, NeuroMatch’s ambulatory EEG capability provides an accessible tool that diagnoses neurological conditions in real-world environments.
Source: LVIS Corporation
About LVIS Corporation
LVIS Corp., founded in 2013 and headquartered in Palo Alto, CA, develops neuroimaging software to visualize and analyze brain networks for diagnosing and treating neurological diseases. Its core product, the NeuroMatch platform, uses algorithms to decode neural information and generate live visualizations for clinicians and researchers. The company serves clinical, research and healthcare sectors, supporting applications in neurology diagnostics and neuroscience studies. LVIS operates globally, with additional offices in Gangnam, Seoul, and Daegu, South Korea, and is affiliated with programs such as Stanford’s StartX and Nvidia’s Inception.